BIOMAT Database Logo BIOMAT Database Logo

[Correlations of kinetics of antipyrine, indocyanine green and bromosulfophthalein in healthy subjects and in patients with cardiovascular diseases]. 1978

H Adamska-Dyniewska, and L Kowalczyk

UI MeSH Term Description Entries
D007208 Indocyanine Green A tricarbocyanine dye that is used diagnostically in liver function tests and to determine blood volume and cardiac output. Cardio-Green,Cardiogreen,Ujoveridin,Vofaverdin,Vophaverdin,Wofaverdin,Cardio Green,Green, Indocyanine
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000983 Antipyrine An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29) Phenazone,Anodynin,Pyramidone

Related Publications

H Adamska-Dyniewska, and L Kowalczyk
Antipyrine, oxazepam, and indocyanine green clearance in patients with chronic pancreatitis and healthy subjects.
August 1999, Scandinavian journal of gastroenterology,
H Adamska-Dyniewska, and L Kowalczyk
Hepatic clearances of antipyrine, indocyanine green, and galactose in normal subjects and in patients with chronic liver diseases.
August 1988, Clinical pharmacology and therapeutics,
H Adamska-Dyniewska, and L Kowalczyk
The clearance of antipyrine and indocyanine green in normal subjects and in patients with chronic lever disease.
July 1976, Clinical pharmacology and therapeutics,
H Adamska-Dyniewska, and L Kowalczyk
Changes in indocyanine green kinetics after the administration of enalapril to healthy subjects.
August 1990, British journal of clinical pharmacology,
H Adamska-Dyniewska, and L Kowalczyk
Changes in antipyrine and indocyanine green kinetics during nifedipine, verapamil, and diltiazem therapy.
August 1986, Clinical pharmacology and therapeutics,
H Adamska-Dyniewska, and L Kowalczyk
[Liver capacity in the biotransformation of drugs in patients with chronic circulatory failure (kinetics of antipyrine and indocyanine green)].
October 1978, Polskie Archiwum Medycyny Wewnetrznej,
H Adamska-Dyniewska, and L Kowalczyk
[Hepatic elimination of indocyanine green and antipyrine in patients with chronic liver disease].
June 1982, Die Medizinische Welt,
H Adamska-Dyniewska, and L Kowalczyk
Thiacetarsamide in dogs: disposition kinetics and correlations with selected indocyanine green kinetic values.
June 1986, American journal of veterinary research,
H Adamska-Dyniewska, and L Kowalczyk
The Effects of Lansoprazole on the Disposition of Antipyrine and Indocyanine Green in Normal Human Subjects.
August 1995, American journal of therapeutics,
H Adamska-Dyniewska, and L Kowalczyk
Blood cadmium in healthy subjects and in patients with cardiovascular diseases.
January 1982, Cor et vasa,
Copied contents to your clipboard!